Benign Malignant Differentiation
Benign Malignant Differentiation - Related Videos
08:33
Three Dimensional Cultures: A Tool To Study Normal Acinar Architecture vs. Malignant Transformation Of Breast Cells
0 Views •
Cited by 22 •
2014
Three dimensional culture of mammary epithelial cells on a reconstituted basement membrane is a useful method to recapitulate the in vivo architecture of the benign breast, and to differentiate the malignant phenotype from the benign breast phenotype. Importantly, this system can be applied to study invasive carcinomas in other tissues.
08:38
Renal Capsule Xenografting and Subcutaneous Pellet Implantation for the Evaluation of Prostate Carcinogenesis and Benign Prostatic Hyperplasia
0 Views •
Cited by 13 •
2013
We describe the manufacture of compressed hormone pellets, as well as subcutaneous surgical implantation into mice. This strategy can be combined with the growth of cell and tissue xenografts under the renal capsule of athymic nude mice to evaluate hormonal carcinogenesis and regulation of benign prostate growth.
08:32
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
0 Views •
Cited by 9 •
2019
Transgenic lck:eGFP zebrafish express GFP highly in T lymphocytes, and have been used to study T cell development and acute lymphoblastic leukemia. This line can be used to study B cells, which express lck at lower levels. This protocol describes purification of malignant and non-malignant B cells from lck:eGFP zebrafish.
07:23
A Protocol for Genetic Induction and Visualization of Benign and Invasive Tumors in Cephalic Complexes of Drosophila melanogaster
0 Views •
Cited by 5 •
2013
Cooperation between an activated oncogene like RASV12 and mutations in cell polarity genes like scribbled, result in tumor growth in Drosophila where tumor cells also display invasive behaviors. Here a simple protocol for the induction and observation of the benign and invasive tumors is presented.
09:39
Normal and Malignant Muscle Cell Transplantation into Immune Compromised Adult Zebrafish
0 Views •
Cited by 16 •
2014
Here, we present a protocol for cell transplantation of zebrafish skeletal muscle and embryonal rhabdomyosarcoma (ERMS) into adult immune compromised rag2E450fs homozygous mutant zebrafish. This protocol allows for the efficient analysis of regeneration and malignant transformation of muscle cells.
FAQs
Microscopic assessment does not rely on a single feature. Pathologists examine growth pattern, cellular differentiation, nuclear atypia, and mitotic activity, then consider whether the tissue shows local invasion or potential for metastasis. Considering these findings together helps distinguish lesions with different expected behaviors and supports more informed diagnostic and prognostic judgments.
Evaluating differentiation and nuclear atypia adds cellular detail to the assessment of a lesion. These findings are interpreted alongside growth pattern and mitotic activity rather than treated as isolated verdicts. Their value lies in contributing to an integrated picture of tissue behavior, which can strengthen classification and help pathologists communicate the likely clinical significance of the findings.
Benign-malignant differentiation depends on more than the presence of cellular atypia. A complete assessment also considers how tissue grows, whether it invades locally, how actively cells divide, and whether metastatic potential is a concern. This broader comparison helps avoid basing classification on one microscopic observation and connects morphology with the expected behavior that informs prognosis and management.
Imaging and clinical findings provide context that microscopy alone may not capture. Pathologists integrate these data with tissue examination to characterize a suspicious lesion, using immunohistochemistry or molecular tests when needed. This multimodal approach is important because classification depends on the combined interpretation of cellular, tissue, and clinical information rather than on laboratory findings in isolation.
Evaluation begins with microscopic examination of the tissue and review of relevant clinical and imaging findings. If the initial characterization requires additional support, immunohistochemistry or molecular tests may be incorporated. The resulting assessment combines these sources to classify the lesion and describe its likely behavior, creating a basis for subsequent diagnostic and treatment decisions.
These ancillary tests are considered when microscopic examination and the available clinical or imaging context do not fully characterize suspicious tissue. They supplement, rather than replace, the broader assessment by adding information that can support lesion classification. Their selective use allows the diagnostic workup to address unresolved features while keeping interpretation connected to morphology and clinical findings.
The classification directly informs the range of management options under consideration. Depending on the assessment, clinicians may choose observation, surgical removal, systemic therapy, or another intervention. It also supports prognosis and risk assessment, helping care teams explain likely disease behavior and communicate decisions using evidence from the lesion's morphology together with imaging and clinical information.